Carborane-Appended Saccharides: Prime Candidates for Boron Neutron Capture Therapy (BNCT) Clinical Trials
نویسندگان
چکیده
Carborane-appended 5-thio-Dglucopyranose (TDG) and deoxyribose derivatives were synthesized and evaluated for accumulation in cancer cells, cytotoxicity, and efficacy in an in vitro boron neutron capture therapy (BNCT) assay. The nidocarborane-appended sugar conjugates were found to be less cytotoxic than their closo-carborane analogues. Biological evaluation with human hepatocellular carcinoma cells (SK-Hep1), bladder (T-24), and prostate (DU-145) cancer cells confirmed that the nido-carborane sugar conjugates were more effectively accumulated than the currently employed boronated agents used in clinical trials, namely boronophenylalanine (BPA) or sodium borocaptate (BSH). BNCT performed with nidocarborane-appended saccharides in a murine squamous cell carcinoma cell line (SCC-VII), indicated lower survival fraction for nido-carborane-appended TDG than that for BPA. These results provide justification for the further development and testing of carboraneappended saccharides for use in BNCT.
منابع مشابه
An Introduction to Boron Neutron Therapy (BNCT): Current Status and Future Outlook
Boron neutron capture therapy (BNCT) is based on the nuclear reaction, such that B-10 irradiated with low-energy thermal neutrons produces alpha particles with high linear energy transfer and lithium-7. Clinically, BNCT is used primarily for treatment of high-grade glioma or brain metastases from melanoma and, more recently, head, neck and liver cancers. Since reactors have long been used to pr...
متن کاملTrivalent galactosyl-functionalized mesoporous silica nanoparticles as a target-specific delivery system for boron neutron capture therapy.
A multi-functional mesoporous silica nanoparticle (MSN)-based boron neutron capture therapy (BNCT) agent, designated as T-Gal-B-Cy3@MSN, was synthesized with hydrophobic mesopores for incorporating a large amount of o-carborane (almost 60% (w/w) boron atoms per MSN), and the amines on the external surface were conjugated with trivalent galactosyl ligands and fluorescent dyes for cell targeting ...
متن کاملInvestigation the potential of Boron neutron capture therapy (BNCT) to treat the lung cancer
Introduction: Boron neutron capture therapy (BNCT) is recommended to treat the glioblastoma tumor. It is well known that neuron beams are more effective treatment than photon beams to treat hypoxia tumors due to interaction of neutron with nucleus and production of heavy particles such as 7Li and alpha particle. In this study to evaluate the suitability of BNCT for treating of ...
متن کاملDesign of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
A multivalent galactosyl carborane derivative 10 (dendritic glyco-borane, DGB) was synthesized and demonstrated as a potential cell-targeting agent in BNCT with HepG2 cells. DGB 10 improved the delivery of boron to HepG2 cells and neutron irradiation data show DGB 10 with ten-fold improvement at killing the HepG2 cells over BSH.
متن کاملClinical potential of boron neutron capture therapy for locally recurrent inoperable previously irradiated head and neck cancer.
This review compares the safety and efficacy of boron neutron capture therapy (BNCT) in the treatment of previously irradiated, inoperable locoregional recurrent HNC patients and compares BNCT against the standard treatment of platinum-based chemotherapy. Our analysis of published clinical trials highlights efficacy of BNCT associated with mild side effects. However, the use of BNCT should be e...
متن کامل